Big Move For ContraFect Corporation
Mon, Feb 07, 2022 at 05:30 PM
ContraFect Corporation (CFRX:NASDAQ) rocketted at $3.25, representing a gain of 18.2%. From Thu, Jan 20, 2022, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Tue, Nov 30, 2021 at $4.28 with a volume of 4M+.
About ContraFect Corporation (CFRX:NASDAQ)
ContraFect Corp is a biotechnology company engaged in the development of protein and antibody therapeutic products for life-threatening infectious diseases. The Company's product candidates are CF-301, CF-404.
Top 10 Gainers:
- Nuvectis Pharma Inc. (NVCT:NASDAQ), 144.62%
- Anghami Inc. (ANGH:NASDAQ), 62.5%
- Origin Agritech Limited (SEED:NASDAQ), 34.53%
- Bakkt Holdings Inc. Class A (BKKT:NYSE), 33.95%
- Luokung Technology Corp. (LKCO:NASDAQ), 24.31%
- Navidea Biopharmaceuticals, Inc. (NAVB:NYSEMKT), 23.19%
- Peloton Interactive, Inc. (PTON:NASDAQ), 20.94%
- Castor Maritime Inc. (CTRM:NASDAQ), 20.25%
- Synthetic Biologics, Inc. (SYN:NYSEMKT), 19.99%
- ContraFect Corporation (CFRX:NASDAQ), 18.18%